Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of Anifrolumab for Children and Teens with Moderate to Severe Lupus

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Poland Portugal Spain
  • Study on Conditioning Treatments with Busulfan, Clofarabine, and Fludarabine for Children with Acute Myeloid Leukemia Undergoing Stem Cell Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Denmark Finland Lithuania The Netherlands Norway +1
  • Study on Roxadustat for Treating Anemia in Children with Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Bulgaria Croatia Czechia Denmark Finland +14
  • Study on Long-Term Safety and Effects of DNL310 for Patients with Mucopolysaccharidosis Type II (MPS II)

    Recruiting

    3 1 1
    Belgium Czechia France Germany Ireland Italy +3
  • Study on Gene Therapy GNT0003 for Patients with Severe Crigler-Najjar Syndrome Requiring Phototherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    France Italy The Netherlands
  • Long-Term Safety Study of MB-CART19.1, MB-CART20.1, and Zamtocabtagene Autoleucel for Patients with Advanced Melanoma or B-Cell Malignancies

    Recruiting

    1 1 1
    Germany
  • Study on Semaglutide and Low Energy Diet for Obesity in Adolescents Aged 12-17

    Recruiting

    3 1
    Investigated Drugs:
    Norway
  • Long-term Follow-up Study for Patients with Solid and Blood Cancers Treated with Brexucabtagene Autoleucel or Axicabtagene Ciloleucel

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Austria Belgium France Germany Italy The Netherlands +1
  • Study on the Safety of Long-Term Use of Deucrictibant for Treating Hereditary Angioedema Attacks in Patients with C1-Inhibitor Deficiency

    Recruiting

    4 1 1
    Austria Bulgaria Czechia France Germany Hungary +8
  • Study on PTG-CARCIK-CD19 for Adults and Children with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

    Recruiting

    1 1 1
    Investigated Drugs:
    Italy